Pharmacokinetics, Pharmacodynamics, and Tolerability of Opicapone in Healthy Chinese and Caucasian Subjects: An Open-Label, Single-Center, Phase  1 Study

ConclusionEthnicity had no significant impact on PK and PD parameters after single or multiple doses of OPC, and OPC was safe and tolerable in healthy Chinese subjects.Trial RegistrationChiCTR number, CTR20192230.

Source: Neurology and Therapy - January 10, 2022 Category: Neurology Source Type: research